UNSPSC 51172018: Piprozolin or piprozoline

This classification denotes a piperidine with the molecular formula C14H22N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7786W0VV8M, chemically known as ethyl 3-ethyl-4-oxo-5-piperidino-.delta.(sup2, .alpha.)-thiazolidineacetate but generally known as piprozolin, which bears US NIH Compound Identifier 28426. European Medicines Agency schedules Piprozolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09889MIG.

World Health Organization schedules piprozolin in its Anatomical Therapeutic Chemical (ATC) Classification. PIPROZOLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C(N2CCCCC2)C(=O)N(C\1=C\C(=O)OCC)CC.

UNSPSC 51172018 Piprozolin or piprozoline is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local activity under this code shows no direct procurement of piprozoline itself. Instead, the code appears in solicitations for broader pharmaceutical and drug-testing services where piprozoline may be one of many substances screened or supplied. State and local governments are actually buying drug-testing services (specimen collection, immunoassay screening, and confirmatory testing), generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles, and pharmacy benefit program support services under this code designation. Issuing bodies include county criminal-justice departments (Collin County Community Supervision and Corrections Department in Texas), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving state and local facilities across participating jurisdictions including Oregon).

Recent activity clusters in Texas and Minnesota. Collin County Community Supervision and Corrections Department released an RFP (2026-327) on July 9, 2026, due July 23, 2026, for offender specimen collection and drug testing services at an estimated contract value of $600,000 over two years with three optional one-year renewals, with annual testing demand of approximately 25,031 tests comprising five-panel and six-panel screens and ancillary testing. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026, to explore direct-to-manufacturer pharmacy prescription programs for state agencies and self-insured health plans, with no award value specified. The Minnesota Department of Administration (administering MMCAP) issued an RFP (S1070000015802) on January 20, 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers to state and local facilities, with evaluation weighted 75 percent on price competitiveness and contract terms effective July 1, 2026. The code shows modest recent activity and mixed relevance to piprozoline as a specific commodity; firms should verify whether responses target the actual substance or the broader pharmaceutical and testing services being solicited.